Yeah it was all looking good. Until it wasn't....
So the solution to the issue you raise CBD is one of two options
1. They go after smaller deals which relative to their market cap they can get over the line with the ASX
or
2. They get the market cap up so they can get deals of a bigger size over the line with the ASX
We all hope for the latter so lets see what comes out from the company in the coming weeks/months re Anagrelide, Zolpimist, and whatever else is in the works.
Yeah it was all looking good. Until it wasn't....So the solution...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 14.5¢ | 14.0¢ | $47.52K | 327.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7168 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 374430 | 9 |
View Market Depth
| Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |